Söderport Fastigheter extends and expands credit facility

  · Söderport Fastigheter has reached agreement on a revolving credit facility
totaling MSEK 3,000
  · The facility will extend until 2020 and is provided by Swedbank
  · MSEK 2,100 will be used to refinance an existing credit facility
  · The facility creates the basis for continued development of the Söderport
Group, while simultaneously reducing the financial risk for the company
Söderport Fastigheter, which Hemfosa Fastigheter owns in equal parts with Sagax,
has today reached an agreement on a revolving credit facility with Swedbank. The
facility totals MSEK 3,000 and has a term that will extend until April 15, 2020.

MSEK 2,100 will be used to refinance an existing credit facility. The remaining
share of the facility provides the basis for the acquisition of properties in
line with the Söderport Group’s strategy. In addition, the move will reduce the
financial risk, since the duration of 65 percent of the Söderport Group’s
interest-bearing liabilities will be extended from one year to just over five
years.

During the first nine months of the year, the Söderport Group recognized profit
from property management totaling MSEK 143. At September 30, the Söderport Group
owned 45 properties with an externally assessed market value of MSEK 4,950.
For  further  information,  please  contact:

Jens Engwall, CEO, jens.engwall@hemfosa.se, mobile phone +46 70-690 6550, office
+46 8-448 04 80
About Hemfosa Fastigheter

Hemfosa is a Swedish real estate company with a well-balanced and geographically
diversified property portfolio focusing on community service properties with the
State and municipalities as the largest tenants. This provides stable cash flows
and a healthy yield. In conjunction with value creation, Hemfosa also aims to
actively participate in the transaction market. At  September 30, 2014, Hemfosa
owned commercial properties in Sweden with a total property value of
approximately SEK 20.5 billion, including the company’s share of the property
value of joint ventures. The company’s share has been listed on Nasdaq Stockholm
Mid Cap since March 21, 2014. Read more at www.hemfosa.se.